Id |
Subject |
Object |
Predicate |
Lexical cue |
T404 |
0-58 |
Sentence |
denotes |
Table 2 Antiviral activities of essential oil components. |
T405 |
59-114 |
Sentence |
denotes |
Essential Oil Component Assay IC50 (μg/mL) Reference |
T406 |
115-182 |
Sentence |
denotes |
(E)−Anethole Plaque reduction assay (RC-37 cells), HSV-1 20 [59] |
T407 |
183-246 |
Sentence |
denotes |
Camphor Plaque reduction assay (Vero cells), HSV-1 2600 [72] |
T408 |
247-327 |
Sentence |
denotes |
Carvacrol MTT assay (Mardin−Darby bovine kidney (MDBK) cells, HSV-1 48.6 [63] |
T409 |
328-400 |
Sentence |
denotes |
β-Caryophyllene Plaque reduction assay (RC-37 cells), HSV-1 0.25 [59] |
T410 |
401-476 |
Sentence |
denotes |
Caryophyllene oxide Plaque reduction assay (RC-37 cells), HSV-1 0.7 [59] |
T411 |
477-544 |
Sentence |
denotes |
1,8-Cineole Plaque reduction assay (Vero cells), HSV-1 1800 [72] |
T412 |
545-613 |
Sentence |
denotes |
1,8-Cineole Plaque reduction assay (RC-37 cells), HSV-1 1200 [52] |
T413 |
614-712 |
Sentence |
denotes |
(E)-Cinnamaldehyde Influenza type A (H1N1) virus 70% at a concentration of 0.53% after 3 h [95] |
T414 |
713-798 |
Sentence |
denotes |
(E)-Cinnamaldehyde H1N1 in-vivo by inhalation in a mouse model 89% inhibition [95] |
T415 |
799-868 |
Sentence |
denotes |
Citral (Geranial + Neral) Yellow fever (YFV), Vero cells 17.6 [62] |
T416 |
869-951 |
Sentence |
denotes |
Citral (Geranial + Neral) Plaque reduction assay (RC-37 cells), HSV-1 3.50 [52] |
T417 |
952-1031 |
Sentence |
denotes |
p-Cymene Influenza, HSV-1, HSV-2, ECHO 9, Cox B1, Polio 1, Adeno 6 >500 [31] |
T418 |
1032-1095 |
Sentence |
denotes |
p-Cymene Plaque reduction assay (RC-37 cells), HSV-1 16 [52] |
T419 |
1096-1152 |
Sentence |
denotes |
p-Cymene Influenza type A (H1N1) virus Inactive [25] |
T420 |
1153-1204 |
Sentence |
denotes |
Dodecanal Influenza type A (H1N1) virus 51 [54] |
T421 |
1205-1268 |
Sentence |
denotes |
β-Eudesmol Plaque reduction assay (Vero cells), HSV-1 6 [59] |
T422 |
1269-1331 |
Sentence |
denotes |
Eugenol Plaque reduction assay (RC-37 cells), HSV-1 35 [59] |
T423 |
1332-1396 |
Sentence |
denotes |
Eugenol Plaque reduction assay (RC-37 cells), HSV-1 25.6 [96] |
T424 |
1397-1461 |
Sentence |
denotes |
Farnesol Plaque reduction assay (RC-37 cells), HSV-1 3.5 [59] |
T425 |
1462-1520 |
Sentence |
denotes |
Germacrone Influenza type A (H1N1) virus 1.22–1.55 [97] |
T426 |
1521-1574 |
Sentence |
denotes |
Germacrone Influenza type A (H3N2) virus 0.34 [97] |
T427 |
1575-1621 |
Sentence |
denotes |
Germacrone Influenza type B virus 1.38 [97] |
T428 |
1622-1689 |
Sentence |
denotes |
Isoborneol Plaque reduction assay (Vero cells), HSV-1 <1000 [98] |
T429 |
1690-1765 |
Sentence |
denotes |
Nerolidol (natural) Plaque reduction assay (RC-37 cells), HSV-1 4.2 [99] |
T430 |
1766-1843 |
Sentence |
denotes |
Nerolidol (synthetic) Plaque reduction assay (RC-37 cells), HSV-1 1.5 [99] |
T431 |
1844-1892 |
Sentence |
denotes |
Octanal Influenza type A (H1N1) virus 15 [54] |
T432 |
1893-1970 |
Sentence |
denotes |
Patchouli alcohol Influenza type A (H1N1) 89% inhibition at 10 μg/mL [100] |
T433 |
1971-2026 |
Sentence |
denotes |
Patchouli alcohol Influenza type A (H2N2) 0.89 [101] |
T434 |
2027-2156 |
Sentence |
denotes |
Patchouli alcohol Influenza type A (H2N2), in-vivo test using a mouse model 70% survival rate at a dose of 5 mg/(kg day) [101] |
T435 |
2157-2221 |
Sentence |
denotes |
α-Pinene Plaque reduction assay (RC-37 cells), HSV-1 4.5 [52] |
T436 |
2222-2288 |
Sentence |
denotes |
Piperitenone oxide Plaque reduction assay (Vero cells) 1.4 [64] |
T437 |
2289-2347 |
Sentence |
denotes |
α-Terpinene Influenza type A (H1N1) virus Inactive [25] |
T438 |
2348-2429 |
Sentence |
denotes |
α-Terpinene Influenza, HSV-1, HSV-2, ECHO 9, Cox B1, Polio 1, Adeno 4 >12 [31] |
T439 |
2430-2497 |
Sentence |
denotes |
α-Terpinene Plaque reduction assay (RC-37 cells), HSV-1 8.5 [52] |
T440 |
2498-2563 |
Sentence |
denotes |
γ-Terpinene Plaque reduction assay (RC-37 cells), HSV-1 7 [52] |
T441 |
2564-2646 |
Sentence |
denotes |
γ-Terpinene Influenza, HSV-1, HSV-2, ECHO 9, Cox B1, Polio 1, Adeno 5 >120 [31] |
T442 |
2647-2705 |
Sentence |
denotes |
γ-Terpinene influenza type A (H1N1) virus inactive [25] |
T443 |
2706-2812 |
Sentence |
denotes |
Terpinen-4-ol Influenza, HSV-1, HSV-2, ECHO 9, Cox B1, Polio 1, Adeno 2 25 (influenza)>50 (others) [31] |
T444 |
2813-2880 |
Sentence |
denotes |
Terpinen-4-ol Plaque reduction assay (Vero cells), HSV-1 60 [52] |
T445 |
2881-2947 |
Sentence |
denotes |
α-Terpineol Plaque reduction assay (RC-37 cells), HSV-1 22 [52] |
T446 |
2948-3052 |
Sentence |
denotes |
Terpinolene Influenza, HSV-1, HSV-2, ECHO 9, Cox B1, Polio 1, Adeno 3 12 (influenza)>12 (others) [31] |
T447 |
3053-3125 |
Sentence |
denotes |
Thujones (α & β) Plaque reduction assay (RC-37 cells), HSV-1 400 [72] |
T448 |
3126-3177 |
Sentence |
denotes |
Thymol Influenza type A (H1N1) virus Active [25] |
T449 |
3178-3239 |
Sentence |
denotes |
Thymol Plaque reduction assay (RC-37 cells), HSV-1 30 [52] |
T450 |
3240-3293 |
Sentence |
denotes |
2-Undecanone influenza type A (H1N1) virus 62 [54] |